Tebao Bio (688278): Investor Relations Activity Record Form CFi.CN Zhongcai Network Post date May 10, 2022 — 23:16 Post Lock Read More [Transaction stock] The hepatitis concept sector fell, and Shuangcheng Pharmaceutical (002693.CN) fell 6.63%-Hong Kong Stocks-Financial Post date May 9, 2022 — 12:30 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Transaction stock] The hepatitis concept sector fell, and Shuangcheng Pharmaceutical (002693.CN) fell 6.63%-Hong Kong Stocks-Financial Post date May 9, 2022 — 12:30 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards. Post date May 7, 2022 — 07:56 Post Lock Read More 4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
4.29. Zhongcai.com at 7pm: Tomorrow's News, Good/Bad News Updating CFi.CN Zhongcai.com Post date April 29, 2022 — 20:30 Post Lock Read More Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Announcement Express of Listed Companies in the Evening of April 29_Sina Finance_Sina.com Post date April 29, 2022 — 18:25 Post Lock Read More On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
On the evening of April 29th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net Post date April 29, 2022 — 16:12 Post Lock Read More Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Caisuo Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Interface News · Securities Post date April 21, 2022 — 09:05 Post Lock Read More Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Caisuo The third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Post date April 21, 2022 — 09:05 Post Lock Read More Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Third-generation insulin revenue doubled, why is Tonghua Dongbao's share price still bottoming out? Tonghua Dongbao_Sina Finance_Sina.com Post date April 21, 2022 — 09:03 Post Lock Read More April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
April 20th Shanghai Stock Exchange Block Trading Information_ Oriental Fortune Net Post date April 20, 2022 — 19:11 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the launch of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing of oral drugs for the new crown – yqqlm Post date April 20, 2022 — 15:02 Post Lock Read More Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Watching the market: 1 share violently pulls up 2 shares and stops in seconds CFi.CN Zhongcai Network Post date April 8, 2022 — 12:05 Post Lock Read More Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Potential suppliers of CanSino and CSPC, the most certain mRNA vaccine sellers! -Finance-financial world Post date April 8, 2022 — 11:40 Post Lock Read More
Caishen.CoCaishen.Co